References
- Amino K, Yuasa T, Kumahara Y. Exophthalmos in autoimmune thyroid disease. J Clin Endocrinol Metab. 1980; 51: 1232–4.
- Winand RJ, Etienne-Decerf J, Wandeleux P. Endocrine exophthalmos. In: De Visscher M (Ed) The thyroid gland. Raven Press, New York, 1980; 363–73.
- Modification of the classification of the eye changes of Graves’ disease: Recommenda tions of the ad hoc Committee of the American Thyroid Association. Letter to the Editor. J Clin Endocrinol Metab. 1977; 44: 203–4.
- Forbes G. Computed tomography of the orbits. In: Leeds NE (Ed) Symposium on Neuroradiology. Radiol Clin N Amer. 1982; 20: 3749.
- Wegener OH (Ed) Whole body computerized tomography. Schering, 1983; 5100 70.
- Bastenie PA, Bonnyns M, Vanhaelst L. Grades of subclinical hypothyroidism in asymptomatic autoimmune thyroiditis revealed by the thyrotropin-releasing hormone test. J Clin Endocrinol Metab. 1980; 51: 163–5.
- Jellinek EK. The orbital pseudotumour syndrome and its differentiation from endocrine exophthalmos. Brain. 1969; 92; 35–58.
- Wall JR, Henderson J. Graves’ ophthalmopathy. CMA Journal. 1981; 124: 855–61.
- Gwinup G, Elias AN, Ascher HS. Effect on exophthalmos of various methods of treatment of Graves’ dusease. JAMA. 1982; 247: 21358.
- Appen RE, Wendelborn D, Nolten WE. Diplopia in autoimmune thyroid disease. Arch Int Med. 1982; 142: 898–901.
- Brownlie BEW, Newton OAG, Sing SP. Ophthalmopathy associated with primary hypothyroidism. Acta Endocrinol. 1975; 79: 691–8.
- Havard CWH. Progress in endocrine exophthalmos. Br Med J. 1979; 1: 1001–4.
- Cennamo G, Bizarro A, Soricelli A et al. Correlation between unilateral exophthalmos and thyroid diseases. Ophthalmologica. 1980; 180: 216–20.
- Volpe R (Ed). Autoimmunity in the endocrine system. Monograhs on Endocrinology. Springer Verlag, Berlin, 1981; 19.
- Kodama K, Sikorska H, Bayly R, Wall JR. Demonstration of a circulating autoantibody against a soluble eye-muscle antigen in Graves’ ophthalmopathy. Lancet. 1982; 2: 1353–6.
- Munro RE, Lamki L, Row VV, Volpe R. Cellmediated immunity in the exophthalmos of Graves’ disease as demonstrated by the migration inhibition factor (MIF) testJ Clin Endocrinol Metab. 1973; 37: 286–9.
- Kriss JP, Konishi J, Herman H. Studies on the pathogenesis of Graves’ ophthalmopathy with some related observations regarding therapy. Recent Prog Horm Res. 1975; 31: 533–8.
- Dandona P, Marshall NJ, Bidey SP, Nathan A, Havard CWH. Successful treatment of exophthalmos and pretibial myxoedema with plasmapheresis. Br Med J. 1979; 1: 374–6.
- Glinoer D, Schrooyen M, Sand G, Winand R. Beneficial effects of plasma exchange therapy for severe Graves’ ophthalmopathy. Abstr Nth annual meeting Eur Thyroid Assoc. Ann Endocrinol. 1984; 45: 13.
- Lewis RA, Slater N, Croft DN. Exophthalmos and pretibial myxoedema not responding to plasmapheresis. Br Med J. 1979; 2: 390–1.
- Kriss J P. Treatment of exophthalmos and pretibial myxoedema with plasmapheresis. Br Med J. 1979; 1: 1149–50.